Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention

BioFactors

Volumn 13, Issue 1-4, 2000, Pages 49-54

  Nakachi, K ^a   Matsuyama, S ^a   Miyake, S ^a   Suganuma, M ^a   Imai, K ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Cancer; Cardiovascular disease; Green tea; Prospective cohort study

Indexed keywords

ADULT; AGE; AGED; CANCER INCIDENCE; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DEATH; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX; SMOKING; SURVIVAL; TEA;

EID: 0034494832     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520130109     Document Type: Conference Paper

References (9)

1. Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea
2. Tea and cancer
3. Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallate
4. Mechanistic findings of green tea as cancer preventive for humans
5. Cancer-preventive effects of drinking green tea among a Japanese population
6. Phase I clinical trial with green tea tablets in a Japanese healthy population
7. Effects of pu-erh tea on lipid metabolism in rats
8. Effects of green tea catechins on plasma cholesterol level in cholesterol-fed rats
9. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases